Cited by 652Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Alzheimer’s Disease: Epidemiology and Clinical Progression

Open access

Tahami Monfared, Amir Abbas, Byrnes, Michael J., White, Leigh Ann, Zhang, Quanwu·2022·Neurology and Therapy

DOI 10.1007/s40120-022-00338-8PMC PMC9095793

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of dementia in older individuals (aged ≥ 65 years). To gain a deeper understanding of the recent literature on the epidemiology of AD and its progression, we conducted a review of the PubMed-indexed literature (2014-2021) in North America, Europe, and Asia. The worldwide toll of AD is evidenced by rising prevalence, incidence, and mortality due to AD-estimates which are low because of underdiagnosis of AD. Mild cognitive impairment (MCI) due to AD can ultimately progress to AD dementia; estimates of AD dementia etiology among patients with MCI range from 40% to 75% depending on the populations studied and whether the MCI diagnosis was made clinically or in combination with biomarkers. The risk of AD dementia increases with progression from normal cognition with no amyloid-beta (Aβ) accumulation to early neurodegeneration and subsequently to MCI. For patients with Aβ accumulation and neurodegeneration, lifetime risk of AD dementia has been estimated to be 41.9% among women and 33.6% among men. Data on progression from preclinical AD to MCI are sparse, but an analysis of progression across the three preclinical National Institute on Aging and Alzheimer's Association (NIA-AA) stages suggests that NIA-AA stage 3 (subtle cognitive decline with AD biomarker positivity) could be useful in combination with other tools for treatment decision-making. Factors shown to increase risk include lower Mini-Mental State Examination (MMSE) score, higher Alzheimer's Disease Assessment Scale (ADAS-cog) score, positive APOE4 status, white matter hyperintensities volume, entorhinal cortex atrophy, cerebrospinal fluid (CSF) total tau, CSF neurogranin levels, dependency in instrumental activities of daily living (IADL), and being female. Results suggest that use of biomarkers alongside neurocognitive tests will become an important part of clinical practice as new disease-modifying therapies are introduced.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40120-022-00338-8

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Alzheimer’s Disease
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Normal Cognitive Aging
Harada, C. N., Love, M. C. N., & Triebel, K. L. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.002 · Cited by 2,649
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · cited 2×
“4% of all deaths attributable to dementia in 2016 [31].”
Background

Show all 74 references

Sorted by citations

Items 501–600 of 652

Study on the relationship between insomnia disorder, PET/CT, and gut microbiota in patients with Alzheimer’s disease
Kang, J., Chen, J., Li, P., Zhao, S., Jing, F., Xie, J., & Dong, C. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1669835
Multi-modal approaches to Alzheimer's disease diagnosis: Combining cognitive assessments with biomarkers and imaging
Afridi, M. A., Khalid, M. M., & Din, R. U. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251394315
Migraine and Dementia: A Narrative Review of Current Evidence
Choudhary, A. K. (2025) · Psikhiatriya · doi:10.30629/2618-6667-2025-23-4-81-92
Pathophysiology of confluent diabetes and Alzheimer’s disease
Shah, D. P., & Krishnakumar, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00014-3
EVALUATION OF NOOTROPIC ACTIVITY OF ETHANOLIC EXTRACT OF EUPHORBIA CYATHOPHORA STEMS ON MICE
(2025) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2025/14.12.9628
The association between individualized functional connectivity disruption and metabolic abnormality in alzheimer’s disease and mild cognitive impairment: insights from multimodal neuroimaging
Gao, Y., Lin, S., Jiang, M. H., Wu, P., Wang, J., Yang, Z., & Liu, Y. (2025) · Neuroradiology · doi:10.1007/s00234-025-03855-z
Physicochemical properties for potential Alzheimer's disease drugs
Gado, S., Ateş‐Alagöz, Z., & Adejare, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00017-x
Additional file 1 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24844648
Additional file 2 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24844709
Additional file 4 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654539
Additional file 5 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654542
Additional file 3 of A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Valencia‐Olvera, A. C., Balu, D., Bellur, S., McNally, T. P., Saleh, Y., Pham, D., Ghura, S., York, J. M., Johansson, J. O., LaDu, M. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654536
Additional file 1 of Differences in the treatment needs of patients with dementia with Lewy bodies and their caregivers and differences in their physicians’ awareness of those treatment needs according to the clinical department visited by the patients: a subanalysis of an observational survey study
Ikeda, M., Toya, S., Manabe, Y., Yamakage, H., & Hashimoto, M. (2024) · Figshare · doi:10.6084/m9.figshare.25405965
Specifics of cerebral atrophy and cognitive impairment in cerebral small vessel disease and Alzheimer's disease
Dobrynina, L. A., Gadzhieva, Z. S., Shamtieva, K. V., Kremneva, E. I., Volik, A. V., Akhmetshina, Y. I., Zabitova, M. R., & Kalashnikova, L. A. (2025) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2025-53-023
Diagnostic accuracy of Alzheimer's Questionnaire in identifying dementia among Filipinos in a tertiary hospital
Ablona, K. A. G., & Cenina, A. R. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251405290
RepAD: A Novel Deep Learning Framework for Robust and Interpretable Multiclass Classification of AD from Brain MRI Images
Pan, W., Wang, H., & Yao, Z. (2025) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0019
Multimodal Deep Learning Approach for Alzheimer's Disease Diagnosis
Casapu, C.-I., & Moldovanu, S. (2025) · doi:10.1109/iseee67817.2025.11304814
Early disruption of neurogenesis and neural architecture by Amyloid-β and Tau during Drosophila developmentPreprint
Sharma, K., Tiwari, N., & Tapadia, M. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.31.696993
Early and progressive retinal microglial changes in APPNL-F/NL-F mouse model of Alzheimer’s disease revealed by an automated image analysis software
Sánchez-Puebla, L., López‐Cuenca, I., Sánchez-Puebla, M. A., Granados, A., RAMIREZ, A., Lloréns, J., Saido, T. C., Saito, T., Nieto‐Vaquero, C., Moro, M. Á., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1712480
Bovine colostrum in modern drug delivery system
Tarcea, M., & Matran, I. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33716-1.00002-9
Dementia, Advance Directives, and Second‐Order Volitions
Hirmiz, R. (2026) · Bioethics · doi:10.1111/bioe.70085
Association between physical activity and cognitive impairment in Chinese older adults: A cross‑sectional study
Zhu, Y., Yang, Y., Li, W., Shi, N., Wang, Y., Nan, J., Zhang, X., Han, L., & Ma, Y. (2026) · Neurological Sciences · doi:10.1007/s10072-025-08772-w
The association between temporal-lobe tensor-based morphometry and plasma amyloid-β in mild cognitive impairment
Nasiri, H., KHOSRAVI, F., Ashrafi, M., Niknam, N., Fard, A. M., Koumleh, B. A., Amirian, M. A., Marnani, S. A. S., Sadeghi, M., Delshad, S., et al. (2026) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2026.109360
Early Identification of Alzheimer's Disease with Advanced AI Method
Gaikwad, B. S., & Kumar, A. S. (2025) · International Conference on Advances in Next-Gen Computer Science (ICANCS) · doi:10.1109/icancs65819.2025.11379781
Next-generation sequencing study identifies the first genes associated with Alzheimer's disease in Bangladeshi population: The CARED study
Hakim, M., Ranjan, R., Ken‐Dror, G., Yusuf, M. A., Uddin, M. N., Mamun, M. T., Mamun, A. A., Kawnayn, G., & Sharma, P. K. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261419066
Ligustilide Attenuates Neuroinflammation and Fibrosis in an Aluminum Chloride-induced Rat Model of Alzheimer’s Disease via mTOR/STAT3 Signaling Inhibition
Sirag, N., Elfadil, H., Ghabban, A. J., Alasiri, A. M., Alnasser, I. R., Bedaiwi, H. S., Alharbi, S. F., Almarwani, M. J., Aljohani, O. M., Hassan, H. M., et al. (2026) · The Keio Journal of Medicine · doi:10.2302/kjm.2025-0017-oa
Alzheimer’s Disease: Molecular Mechanisms of the Disease and Involved Factors — A Comprehensive Narrative ReviewPreprint
Leminie, A. A. (2026) · Preprints.org · doi:10.20944/preprints202603.0482.v1
Single odor identification in subjective cognitive decline, mild cognitive impairment and Alzheimer’s dementia
Tasnim, A., & Lehrner, J. P. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-026-02721-z
Meta-Heuristic Optimized Dual-Branch CNN- Transformer with Attention-Guided Multimodal Fusion for Alzheimer’s Diagnosis
Christybai, P. J., & Priya, R. (2026) · International Conference on Electronics and Renewable Systems (ICEARS) · doi:10.1109/icears67481.2026.11416581
Machine learning and free energy clustering reveal PAH protein binding linked to AD risk
Chen, C., He, Y., Ni, Y., Song, D., Chu, M., & Zhang, W. (2026) · iScience · doi:10.1016/j.isci.2026.115311
Restoring amyloid clearance: Z17 promotes astrocytes to clear Alzheimer's plaques via CHI3L1 inhibition
Nada, H., Zhang, L., Kaur, B., García-Vázquez, N., & Gabr, M. T. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151402
Heterogeneity in diagnostic trajectories of ADNI participants
Winalai, C., Mogharbel, N., & Bicout, D. (2026) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2026.110748
Demenzen
Wetzel, A.-J., & Wuttke, A. (2026) · Psychotherapie im Alter · doi:10.30820/1613-2637-2026-1-9
Exercise improves cognitive function in Alzheimer’s disease via the CRNDE/miR-338-3p axis
wang, S., Chen, J., Wang, X., Xu, Y., & He, T. (2026) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2025-0381
Neurobiological links between Alzheimer’s disease and reward system dysfunction
Harutyunyan, H. S., Minasyan, R., Kalueff, A. V., & Yenkoyan, K. B. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.03.028
Development and validation of an eye-tracking-based cognitive impairment screening system for older adults in China: a cross-sectional study
Si, W., Ma, X., Lin, J., Xu, T., Wang, R., Zhu, A., & Cao, W. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106412
Synthesis and biological activity of 6-ferrocenyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amines
Serebrennikova, P. O., Paznikova, Y. A., Kazakova, E. D., Kirnos, E. A., Musikhina, A. A., Рудакова, Е. В., Kovaleva, N. V., Boltneva, N. P., Ganebnykh, I. I., Makhaeva, G. F., et al. (2026) · Russian Chemical Bulletin · doi:10.1007/s11172-026-4879-4
The role of syndecans in pathological protein aggregation
Hudák, A. (2025) · doi:10.14232/phd.12604
Epidemiologic and clinical features of Alzheimer’s disease: a hospital study based on the memory clinic in Abidjan, Côte D’ivoire, Sub-Saharan Africa
Kouassi, K. L., Ehoulan, F. R. E. A., Beuseize, A., Broh, N. Y. C., Souza, A. N. T. E.-D., Yeo, S., Abbé, A. S., & Doumbia-Ouattara, M. (2026) · BMC Neurology · doi:10.1186/s12883-026-04867-9
Speech Analysis From a Dyadic Interaction Social Skills Assessment Task in Mild Cognitive Impairment and Normal Cognition
Badal, V. D., Campbell, L. M., Harvey, P. D., Pinkham, A. E., Moore, R. C., & Depp, C. A. (2026) · The American Journal of Geriatric Psychiatry Open Science Education and Practice · doi:10.1016/j.osep.2026.03.006
Fusion of Multi‐Paradigm EEG Microstate Features to Enhance the Recognition of Mild Cognitive Impairment
He, L., He, X., Li, X., Wang, S., Ji, C., Yin, F., Yang, X., He, Y., Zuo, P., & Gao, J. (2026) · Brain and Behavior · doi:10.1002/brb3.71398
Explainable Patient-Level Cognitive Impairment Screening via Temporal, Semantic, and Psycholinguistic Multimodal AI
Abdullah, A., Fatima, Z., Ruiz, M. J. T., Espinosa-Sosa, O., Sanchéz-Mejorada, C. G., Quintero, R., Rodríguez, J. L. O., & Sidorov, G. (2026) · Journal of Intelligence · doi:10.3390/jintelligence14040066 · Cited by 1
Comorbidities and their Impact on Disease Progression: Focused on Alzheimer's Disease
Sonawane, G., Pansare, K. V., Sonawane, D. D., Patil, C. D., & Mahajan, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010012
Role of Biomarker in Treating Alzheimer's Disease
Anand, P., Kumar, D., Gupta, S., Tiwari, J., & Singh, S. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010006
Alzheimer’s disease: Pathophysiology, current and emerging therapeutic approaches for Alzheimer’s disease
Kumar, I., Rani, D., & Pathania, K. (2026) · Current Trends in Pharmacy and Pharmaceutical Chemistry · doi:10.18231/j.ctppc.39626.1776405949
Case Studies and Patents in Alzheimer’s Disease Research
Kumar, D., Anand, P., Tiwari, J., & Singh, S. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010016
Digital Tools and Artificial Intelligence in Alzheimer’s diagnosis
Yadav, S. D., Goel, S., Tyagi, A., & Bansal, K. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010008
Natural Products and Phytochemicals in Alzheimer’s Management
Tyagi, S., Tyagi, A., Ilma, B., & Shekhar, N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010009
MRI-based correlations of mesial temporal atrophy, hippocampal volumetry, and inferior lateral ventricle–hippocampus ratio in Alzheimer’s dementiaPreprint
takaliuang, D. S., Muljadi, R., Sutanto, R., Situmeang, R., & cucunawangsih (2026) · Research Square · doi:10.21203/rs.3.rs-8824555/v1
National trends and disparities in Alzheimer disease’s mortality (1999–2023) with scenario projections and a data-driven LSTM sensitivity analysis to 2043
Bdair, M., Zahran, A., Jallad, H., Barham, I., Qubbaj, A., Aburabi’e, M., Jarrar, B., Aburajab, J., Alsafareeni, Z., Mansor, A., et al. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02250-w
A perspective for alzheimer disease from gut microbiota-associated NMR-based fecal metabolomics: a study with 5XFAD mice
Tekin, N., Şahin, F., Şahin, B., Kaya, Z. Z., Yılmaz, A., Graham, S. F., Serteser, M., & Baykal, A. T. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01848-2
SHAP-Based Interpretion of Machine Learning Prediction Models for Mild Cognitive Impairment
Wang, Z., Ding, Z., Liu, C., Zhong, B., & Lu, J. (2026) · Communications in computer and information science · doi:10.1007/978-981-95-6739-3_30
Genetic correlation analysis of Alzheimer's disease and stroke implicates PHLPP1 as a shared locus in individuals of African ancestry
Ray, N. R., Kurup, J. T., Kumar, A., Rajabli, F., Wang, L., Xu, W., Jin, F., Yılmaz, E., Kızıl, Ç., Nasciben, L. B., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71433 · Cited by 1
Salidroside mitigates cognitive deficits in AlCl3 exposed aging mouse by modulating APP processing and mitochondrial dysfunction
Dong, Y., Jin, H., Wang, S., & Xu, Y. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1802923
Advancing Diagnostic Depth: ResNet Framework for Early Alzheimer's Disease Identification
Das, A., Roy, T. S., Majumder, B. D., & Ghosh, M. (2025) · International Conference on Emerging Trends in Electronic Devices and Computational Techniques (EDCT) · doi:10.1109/edct65302.2025.11496109
Generative Models in Medical Imaging for Cognitive Disease Detection
Jothe, J. S., Naitam, M. G., Ponmariappan, S., & Pandey, A. C. (2026) · Cognitive systems monographs · doi:10.1007/978-3-032-18782-6_3
Disentangling global atrophy burden from local structural patterns reveals clinically relevant heterogeneity in mild cognitive impairment
Yang, X., Lyu, J., Wang, J., & Quan, Y. (2026) · BMC Neuroscience · doi:10.1186/s12868-026-01035-0
THE ROLE OF PERIODONTITIS IN THE INITIATION AND PROGRESSION OF COGNITIVE DISORDERS: AN UMBRELLA REVIEW
Giuliani, C., Schmidlin, P. R., & Fakheran, O. (2026) · Journal of Evidence Based Dental Practice · doi:10.1016/j.jebdp.2026.102307
Functional autonomy, comorbidities and cognitive decline: a mediation analysis in neurocognitive disorders
Valente, G., Bauco, C., Bucca, C., Corte, F., Petrillo, A., Tonietti, D., Sturco, N. D., & Diotaiuti, P. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1776156
Investigation of the myelin-amyloid interplay in Alzheimer’s disease: insights from novel dsCMA imaging in mouse and human brains
Xu, H. X., Nanda, S., Sun, J., Rudd, M., Gou, L., Marks, H. L., Williams, C. K., Magaki, S., Vinters, H. V., Hintiryan, H., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02317-8
OptiSA-GC++: A mixup-regularized spatial attention framework optimized for Alzheimer’s and MCI subtype classification
Singh, S. G., Hazarika, B. B., & Gupta, D. D. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.110593
Defining Subtle Cognitive Impairment: A Systematic Review of Neuropsychological CriteriaPreprint
Gonalez‐Duran, L., Ilundáin, J. E., Ríos‐Rivera, M. M., Montoya, G., & Riverol, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9629813/v1
Beyond traditional tests: Assessing face recognition in mild cognitive impairment
Tepe, O., Karataş, M. C., Söyler, H. Ç., Kumral, D. E., & Amado, S. (2026) · The Clinical Neuropsychologist · doi:10.1080/13854046.2026.2674008
CLIS: Causality-inspired Longitudinal Image Synthesis and its application to Alzheimer’s disease characterization
Li, Y., Li, H., Xu, Z., & Zhou, S. K. (2026) · Medical Image Analysis · doi:10.1016/j.media.2026.104126 · Cited by 1
Identifying influential environmental drivers of Alzheimer's disease at the county level using machine learning and explainable artificial intelligence
Martins, R., Cao, Y., & Wu, J. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261449503
Identification and validation of glycosylation-related biomarkers in the hippocampus for Alzheimer's disease diagnosis and drug repurposing
Mu, Y., Yu, S., Yang, Z., Chen, S., & Sun, J. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179014
Herbosomal nanocarriers using natural-origin surfactants: a quercetin-based strategy for Alzheimer’s disease and oxidative-stress–driven neurodegeneration
Okda, M., El-Masry, S. M., Helmy, M. W., & Abbas, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-53290-0
Naming performance in bilinguals with Alzheimer's disease and mild cognitive impairment
Sainz-Pardo, M., Hernández, M., Suades, A., Juncadella, M., Ortiz‐Gil, J., Ballester, L. U., Sala, I., Lleó, A., & Calabria, M. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261452694
Combining plasma biomarkers and cognitive challenge tests enhances prediction of functional trajectories of decline among older adults with cognitive impairment
Zheng, D. D., Curiel, R. E., Ortega, A., Crenshaw, K. H., Crocco, E., Vaillancourt, D. E., Armstrong, M. J., Wang, W.-E., Asken, B. M., Adjouadi, M., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261453396
Design and evaluation of a chalcone-based dimeric scaffold targeting amyloid-beta plaques for early detection of Alzheimer's disease: synthesis, radiolabeling, in vivo studies, and integrated molecular docking and dynamics simulation
Ghiamaty, Z., Akhlaghi, M., Jokar, S., Hafezi, H., Bavi, O., Sharifzadeh, M., Sabzevari, O., Ardestani, M. S., Ghorbandaeipour, T., Asadi, M., et al. (2026) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.46659
Emotion Perception in Behavioral Variant Frontotemporal Dementia and Alzheimer Disease: The Parahippocampal Conundrum
Morais, R. F., Duro, D., Pires, R. G., Lemos, R., Lima, M., Oliveira, T. G., & Santana, I. J. (2026) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000420
A review on thymoquinone: a promising therapeutic molecule in Alzheimer's
Kaur, S. D., SINGH, V. A., Kaurav, H., Nangare, S., & Vihal, S. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2026.2682949
Lipid-based nanocarriers for Alzheimer's disease: Design strategies, targeting mechanisms, and therapeutic performance
Yusuf, A., Harati, R., Greish, K., & Haider, M. A. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108594
Examining of the mechanism by which Yin Huang Ge compound alleviates cognitive dysfunction in Alzheimer’s disease mice through modulation of Aβ degrading enzymes and neurotrophic factors
Hao, Y., Yang, H., Zhong, J., Zhang, J., He, X., & Dong, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1821074
Rational design of an environment-sensitive fluorescent probe for monitoring butyrylcholinesterase activity and its application in Alzheimer's disease
Guo, N., Wang, F., Wang, Y., Du, J., ZHANG, Q., Cao, W., Su, J., Zhao, F., Wang, J., Pang, X., et al. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00363j
Self-citation
From Tradition to Translation: A Critical Appraisal of Bacopa monnieri for Neuroprotection from Preclinical and Clinical Perspectives and Challenges in Utilization
Olajide, A. T., Aunsorn, S., Kehinde, S. A., Kaewmanee, T., & Chusri, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125488
The evolving burden of early-onset Alzheimer's disease and other dementias in BRICS countries: Insights from the Global Burden of Disease Study 2023 and projections to 2035
Yang, L., Zeng, J., Luwen, H., & Li, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460745
Neuroprotective phytonutrients: Mechanisms of action and evidence in neurotoxic and degenerative conditions
Oritsemuelebi, B., Ben‐Azu, B., Oyagbemi, A. A., Awogbindin, I. O., Chidebe, E. O., Onuelu, J. E., Iwhiwhu, P., Ohuche, J. C., Esuku, D. T., & Oghorodi, A. M. (2026) · Advances in neurotoxicology · doi:10.1016/bs.ant.2026.03.002
Integrated in-silico design of multitarget Imidazo[1,5-a]pyridine-3-carboxamide inhibitors of cholinesterases and glycogen synthase kinase-3β for Alzheimer’s disease therapy
Onyekwere, O., Otaru, H. A., Ajala, A., Elebo, A., Ramu, R., & Kumar, N. (2026) · Scientific African · doi:10.1016/j.sciaf.2026.e03479
Sinigrin as a dual modulator of oxidative stress and neuroinflammation: Targeting Nrf-2-NF-κB crosstalk in Alzheimer’s disease
Jain, S., Kaur, R., & Singh, S. (2025) · Neurophysiology · doi:10.1007/s11062-026-10022-4
“Behavioral and Neuroinflammatory Evaluation of a Novel Isoxazole-5-One Derivative in Animal Models of Alzheimer’s Disease via TNF-α, COX-2, IL-6, and NF-κB Modulation”
Gohar, N., Abbas, M., Masaud, S. M., Zulfiqar, I., Jabeen, H., Malik, N. S., & Nadeem, H. (2026) · ACS Omega · doi:10.1021/acsomega.6c01108
Computational Evaluation of Oleuropein Interactions with Alzheimer's Disease-Related Proteins Using Molecular Docking and Molecular Dynamics
Elshekh, A., Abdelmaguid, A. M., Eltanany, R. M. A., El-kordy, Y. H., Khedr, A. A., Mekkawy, S. A., El‐Khadragy, M. F., Albrakati, A., Abdelfattah, M. S., & Moneim, A. E. A. (2026) · Journal of Visualized Experiments · doi:10.3791/71430
Advances in the Diagnosis and Management of Alzheimer’s Disease
Joshi, P., Tsai, P., Alix, A., & Gopalakrishna, G. (2026) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2026.05.004
Memory Protectors: Leveraging Artificial Intelligence for Early Detection, Progression Prediction, and Personalized Care in Alzheimer's Disease Management
Krishnamurthy, R., Ali, M. F., Sunena Rose, M. V., Ravi, A. T., Sujitha, R., & Israni, K. (2026) · International Conference on AI, Data Science, Cyber Security and Smart Manufacturing for Sustainable Development (ICADCS) · doi:10.1109/icadcs70036.2026.11583061
Genetic Associations with Temporal Modeling of Alzheimer’s Disease Progression Supports a Novel Paradigm for Disease RiskPreprint
Jordan, D. M., Kritzer, E., Thompson, R. C., Lund, A. N., Patel, T., Grice, A. B., John, D., Initiative, A. D. N., Initiative, A. D. N., Goate, A., et al. (2026) · medRxiv · doi:10.64898/2026.07.07.26356710
BiGranMolNet: A deep learning method for predicting blood-brain barrier permeability based on Bi-Granularity Molecular Graphs
Wang, Y., Wang, Y., Wang, Y., & Wang, J. (2026) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2026.105079
Prefrontal Hemodynamics Underlie the Synergistic Effect of Tai Chi Combined with Transcranial Direct Current Stimulation on Memory in Patients with MCI: An Exploratory fNIRS Study
Liufu, L., Wu, M., Zeng, P., Yang, Y., Chen, C., Huang, J., Lin, S., Liu, H., & Xu, Y. (2026) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2026.100709
In silico pipeline for GSK 3β inhibitor discovery in Alzheimer’s disease using pharmacophore screening, docking, ADME filtering, and MD validation
Elkotamy, M. S., Elgohary, M. K., Alkotami, A. S., Eldesouki, M. M., Elsayed, Z. M., Mattar, A. A., Abo-Ashour, M. F., Tawfik, H. O., Eldehna, W. M., & Abdel‐Aziz, H. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-56505-6
Selective 10-Hz photic driving deficit shared between Alzheimer's and frontotemporal dementiaPreprint
Velez-Pardo, P., Monsalve, R. M., Vasquez, D., Cortina, S. C., & Guevara, E. M. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7271529
Krüppel-like factors KLF5 & KLF8 emerge as potential master transcriptional regulators of Alzheimer’s disease, as revealed on cell fate regulomes in human brain organoidsPreprint
Aubert, A., Comby, A.-C., Bramoulle, A., Mendoza-Ferri, M. G., Azzolin, P., Li, H., Moussy, A., Das, S., Colombo, B. M., & Mendoza-Parra, M. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.23.740401
2-(Arylamino)thiazol-4(5H)-ones Mitigate Oxidative Stress and Confer Neuroprotection in Cellular and Drosophila Models of Alzheimer’s Disease
Selvaraj, N. R., Vijaya, B. S., Nandan, D., San, S., Nair, S. S., Nair, B. G., Venugopal, P., Aradhya, R., & Nair, V. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156642
Design, Synthesis, and Evaluation of Novel Phenoselenazine Derivatives as Potent Modulators of Aβ42 Aggregation
Hefny, A. A., Karuturi, R. C., Madhuranthakam, C. M. R., & Rao, P. P. N. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01959
Herbal Nano-Nootropics in Mental Health: Modulating Neurotransmitters and Oxidative Stress in Depression and Alzheimer’s Disease
(2026) · doi:10.47278/book.tl/2026.478
Chitosan-based hydrogel for intranasal drug delivery; current advances in the brain diseases treatment
Abouali, O., Mokabber, A., Naderpour, S., Vojoudi, E., Sefat, F., Saeinasab, M., Rahimzadegan, M., & Nosrati, R. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127259
Metabolomic Discoveries for Traditional Chinese Medicine Efficacy in Alzheimer′s Disease
Sun, H., Huang, D., Yang, F., Zhang, P., Yang, D., & Zeng, C. (2026) · BioMed Research International · doi:10.1155/bmri/2455800
Impacts of stressful life events in childhood and adulthood on motoric cognitive risk syndrome among older adults with diverse circadian syndrome statesPreprint
Cheng, Z., Wenlong, W. A. N. G., Zhang, M., Wu, J., Ma, W., & Xu, X. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7234316
Emerging neuroprotective mechanisms and therapeutic potential of natural polysaccharides in Alzheimer's disease
Muhammad, N., Ai, R., Yang, L., Cui, Y., Wang, L., Weng, S., Wang, Y., Kakar, M. U., Khan, S., Ahmad, S., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1877358 · Cited by 1
THERAPY FOR ALZHEIMER’S DISEASE - FOCUS ON LECANEMAB
Jońca, M., Majchrowicz, G., Kurys, N., Piekarska, W., Litke, S., & Gołacka, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.5795
Alzheimer’s Disease
Rheaume, B., Whisenhunt, K., Lainoff, E., Sporn, K., & Lee, A. G. (2026) · Springer eBooks · doi:10.1007/978-3-032-26761-0_4
A randomized phase 1b/2 trial of ABBV‐916 in adults with early Alzheimer's disease
Lynch, S. Y., Wang, Y., Wang, D., Bachhav, S. S., Xiong, H., Boiser, J. C., Stage, E., Bannon, A. W., Graff, O. X., & Florian, H. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71715

Authors: Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q.
Affiliations: Eisai (United States) (US)
ORCID: Byrnes, Michael J.
Zhang, Quanwu
Venue: Neurology and Therapy
Publisher: Springer Science and Business Media LLC
Published: 2022-03-14
Volume: 11
Issue: 2
Pages: 553-569
ISSN: 2193-6536 (ISSN-L)
2193-8253
DOI: 10.1007/s40120-022-00338-8
PMC: PMC9095793
OpenAlex: W4221041873
Cited by: 629
References: 74
Citations by year: 2026: 161 · 2025: 208 · 2024: 161 · 2023: 80 · 2022: 19
FWCI: 20.14
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/4.0 (tdm)
creativecommons.org/licenses/by-nc/4.0 (vor)
Locations: Neurology and Therapy (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Funders: Eisai
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: Alzheimer's disease, clinical progression, mild cognitive impairment, amyloid-beta deposition, neurodegeneration, preclinical Alzheimer's disease, disease risk factors, APOE ε4, white matter hyperintensities, entorhinal cortex atrophy, cerebrospinal fluid biomarkers, tau protein, neurogranin, dementia mortality, underdiagnosis, disease-modifying therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alzheimer’s Disease: Epidemiology and Clinical Progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks